<DOC>
	<DOCNO>NCT01748656</DOCNO>
	<brief_summary>Patients OHS efficiently manage long term home-based nocturnal noninvasive positive pressure ventilation ( NIPPV ) . Several NIPPV device offer feature automatically adjusting pressure support ( and/or respiratory back-up rate ) basis pre-determined `` ideal tidal volume '' `` ideal ventilation '' . However algorithms use achieve ideal target different among different commercialize device relative efficacy algorithm compare another remain unknown . The main objective study compare two commercialized NIPPV option</brief_summary>
	<brief_title>Target Volume Noninvasive Positive Pressure Ventilation</brief_title>
	<detailed_description>RESMED Stellar-150 ( IVAPS mode ) versus PHILIPS-RESPIRONICS A30 ( AVAPS-mode ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
	<criteria>Patient Obesity hypoventilation Syndrome ( BMI≥ 30 kg/m2 diurnal PaCO2 ≥ 45mmHg diagnosis exclusion others cause hypoventilation ) 18 75 year old In stable state treat nocturnal NIPPV 3 month adherent NIPPV ( 4h/night ) . patient treat additional long term Oxygen therapy Patient previously treat AVAPS mode IVAPS mode</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Noninvasive ventilation</keyword>
	<keyword>Obesity Hypoventilation Syndrome</keyword>
</DOC>